Do people with vasculitis and other autoimmune rheumatic diseases mount an effective response to COVID-19 vaccination, and how long does it last for?

Project summary:

The aim of the Vasculitis study, in collaboration with Nottingham University Hospitals NHS Trust, is to examine the immune responses to vaccination in individuals with vasculitis compared to age-matched healthy controls. Specifically, the study will examine both the humoral immune responses and deep phenotype T cell responses to vaccination. 


Vasculitis UK

Leader researcher:

Professor Lucy Fairclough

Lead institution:

The University of Nottingham

Vaccine type:


Recruitment for clinical trial open: